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ABSTRACT 
The delivery of ibuprofen into and through the skin from novel formulations containing 
TEMPO-oxidized cellulose nanofibril-based (TOCN) gels was compared to that from two 
conventional and commercially available products. The gels were evaluated in-vitro (using 
both silicone membranes, and pig skin) and in-vivo in human volunteers.  All gels showed 
consistent behaviour in a standard in vitro release test.  The stratum corneum (SC) uptake 
and skin penetration of ibuprofen in vitro from the novel gels and the marketed formulations 
were generally comparable even though the drug loading in the TOCN-based vehicles was 
only 20% of that in the ‘reference’ products.  In vivo, the new gels appeared to enhance drug 
uptake into the SC following a relatively short application time, again matching the 
performance of the commercial formulations.  Taken together, the results of this research 
provide proof-of-concept for the idea that the sustainable, oxidised cellulose gels may provide 
more efficient drug delivery into and through the skin, thereby improving drug utilisation and 
reducing potential adverse effects when such formulations are applied chronically over large 
skin areas. 
 
Graphical abstract 
 
 
  
  
INTRODUCTION 
Ibuprofen is a non-steroidal anti-inflammatory drug that is applied to the skin to treat the local 
pain and inflammation associated, for example, with arthritis and other musculo-skeletal 
problems (Patel et al., 2013). A number of ibuprofen gel formulations are commercially 
available and typically contain the drug at a concentration of 5% w/w.  Common components 
of these formulations include an alcohol (such as ethanol, isopropanol, alone or in 
combination), a gel-forming polymer, such as Carbomer®, chitosan, hydroxyethylcellulose, or 
hydroxypropyl cellulose, a skin penetration enhancer (e.g., propylene glycol), a compound to 
adjust pH (triethanolamine, sodium acetate), an antimicrobial and/or antioxidant, and water 
(Wisniewski and Gemborys, 1992).  The composition of the formulation, not unexpectedly, 
can have a significant impact on the delivery of ibuprofen into the stratum corneum (SC), its 
subsequent transfer to the viable skin layers and, ultimately, to its ability to reach the intended 
subcutaneous tissue target.  The literature, in fact, reports studies which show, despite most 
products containing 5% w/w of drug, that the uptake and delivery of ibuprofen is not always 
the same (Hadgraft et al., 2003; Herkenne et al., 2007a). 
Cellulose is the most abundant biomass in nature and it is a material that has found multiple 
applications and uses involving fibres, membranes, nanocomposites and polymers. The 
mechanical strength, biocompatibility, hydrophilicity and optical properties of cellulose are 
particularly attractive features in many fields of research and development (Qiu and Hu, 2013); 
for example, polymeric systems integrated with cellulose have been seriously considered for 
applications in drug delivery, and stimuli-responsive hydrogels based on cellulose have been 
used to release drugs by modifying environmental factors such as temperature and pH 
(Prabaharan and Mano, 2006; Sannino et al., 2009).  More classically, cellulose-polymer 
combinations have also been used to create controlled release formulations (Fang and 
Cathala, 2011; Tan et al., 2010). The hydrophilic properties of these hydrogels are especially 
attractive because of their water solubility and the fact that drug release can be sensitively 
modulated in response to changes in electrolyte composition as well as other factors already 
mentioned (e.g., temperature and pH) (Çaykara et al., 2006; Pourjavadi et al., 2007, 2006) 
In this study, the performance of two over-the-counter ibuprofen gels has been compared with 
that of novel formulations prepared with TEMPO-oxidized cellulose nanofibrils (TOCN), which 
are derived from natural, renewable sources, unlike the synthetic polymers that are used in 
the products currently on the market.  TOCN provide a non-irritant, colourless, odorless 
material which can be used as a thickener in pharmaceutical, personal care and cosmetic 
products (Crawford et al., 2012).  Oxidised cellulose, in general, has found many uses in the 
pharmaceutical industry (Dol’berg et al., 1973; Pines and Cunningham, 1984; Kaputski et al., 
1995; Zhu et al., 2004; Shimotoyodome et al., 2011; Jia et al., 2016). TOCN also have good 
suspending power and tolerate alcohols and hydrophobic moieties well, thereby providing a 
promising material for use in aqueous formulations (Crawford et al., 2012; Dol’berg et al., 
1973; Pines and Cunningham, 1984; Zhu et al., 2004). Indeed, it has been suggested that the 
combination of low molecular weight alcohols (ethanol, propanol) with TOCN can yield gels 
even in the presence of surfactants (Crawford et al., 2012). Here, the use of TOCN in 
hydroalcoholic formulations for topical drug delivery is demonstrated for the first time and the 
delivery of ibuprofen from these vehicles, relative to two products on the market, is examined. 
  
MATERIALS & METHODS 
Materials: Ibuprofen ( ≥98% GC), sodium dodecyl sulfate (ACS reagent, ≥99.0%), acetonitrile 
(HPLC grade, ≥99.9%), hydrochloric acid (ACS reagent, 37%), triethylamine (≥99%) and 
phosphoric acid (≥99%) were purchased from Sigma Aldrich (Gillingham, UK). Sodium 
chloride (99.7+%), potassium chloride (99.5+%), sodium phosphate (99+%) and potassium 
phosphate (99+%) were from Fisher Scientific (Leicestershire, UK).   
The commercial gels, Sainsbury’s Ibuprofen and IbuleveTM, were purchased from Sainsbury’s 
Pharmacy (Bath, UK) and Diomed Developments Ltd (Hertfordshire, UK), respectively. 
Artificial silicone membrane (serial number 7-4107, thickness 75 μm) was donated by Dow 
Corning Ltd. (Cardiff, UK). 
Abdominal porcine skin (B&J Pigs Ltd, Somerset, UK) was acquired immediately post-
sacrifice. After cleaning and trimming off coarse hairs, the tissue was dermatomed (Zimmer® 
Electric Dermatome, Warsaw, IN) to a nominal thickness of ~750 μm. The skin was stored at 
-20°C and used within three months. 
Cellulose nanofibres were prepared from purified α-cellulose (Croda International Plc, East 
Yorkshire, U.K.) by 2,2,6,6-tetramethyl-piperidin-1-yl)oxyl (TEMPO)-mediated NaOCl/NaBr 
oxidation in water, followed by mechanical dispersion as described previously (Isogai et al., 
2011; Saito et al., 2006). The process, if taken to completion, would generate water-soluble 
poly(glucuronic acid), but here the reaction was limited to 20-25% by controlling the quantity 
of oxidant used (Crawford et al., 2012). The TEMPO-oxidized cellulose nanofibril (TOCN) 
dispersion was subsequently dialysed (MWCO 12000 dialysis membrane, diameter 16 mm, 
Sigma Aldrich, Gillingham, UK) in deionised water for a week (changing the medium three 
times each day). The resulting product was then freeze-dried and dispersed, at room 
temperature, overnight with stirring, in deionised water (Milli-Q water, 18.2 MΩ cm-1) to form a 
stock solution of 2% w/w at pH 6.5. Finally, the dispersion was sonicated for 30 minutes (Vibra 
Cell Sonicator (Sigma Aldrich, Gillingham, UK) at a 50%, 1Hz duty cycle and at 2 W cm-2) 
using an ultra-high intensity tip of 3 mm diameter. 
Formulation of TOCN gels: Hydroalcoholic, ibuprofen-containing TOCN gels were prepared 
from the aqueous stock dispersion. The drug was first dissolved in ethanol and the cellulose 
dispersion was then added.  Five 1% w/w ibuprofen formulations, differing in the amount of 
TOCN, were prepared and compared with Sainsbury’s Gel and IbuleveTM in the experiments 
described below.  The compositions of the TOCN formulations and of the commercial products 
are in Table 1. 
 
Table 1: Components (in %w/w) of the ibuprofen gel formulations studied. 
Formulation Ibuprofen 
Aqueous TOCN 
dispersiona 
Ethanol SDS 
Propylene 
glycol 
A 1.0 60 37 - 2.0 
B 1.0 60 39 - - 
C 1.0 60 39 - - 
D 1.0 60 39 - - 
E 1.0 60 39 0.07 - 
Sainsbury’s Gel 5.0 
hydroxyethylcellulose, sodium hydroxide, benzyl 
alcohol, isopropyl alcohol, purified water 
IbuleveTM 5.0 
industrial methylated spirit, carbomer, propylene 
glycol, diethylamine, purified water 
a For formulations A, B and E, the aqueous dispersion was prepared at a concentration of 1.8% w/w 
TOCN; for formulations C and D, 1.2% w/w and 0.6% w/w TOCN were used, respectively. 
Formulation viscosities were determined using a Bohlin C-VOR viscometer (Malvern 
Instruments, MA, US) equipped with CP 4/40 cone and plate (4° cone angle and 40-mm cone 
diameter). Experiments were performed at 25°C using approximately 5 g of formulation for 
each (mean of three) measurement. Shear rate ranged between 0.01 and 100 s-1. Each 
measurement was repeated three times and the results were averaged.  
Formulation pH was measured (again, in triplicate) using a pH meter (Orion 420Aplus, Thermo 
Scientific, US) that had been pre-calibrated with buffer solutions at pH 4, 7 and 10.  
Ibuprofen analysis: Ibuprofen was quantified by high-performance liquid chromatography 
(Jasco, Great Dunmow, UK) using a Dionex Acclaim 120 column (C18, 5 µm, 4.6 x 150 mm, 
Thermo Scientific, US), with UV-vis detection at 227 nm (Waters, Milford, MA), and a mobile 
phase of 60:40 v/v acetonitrile/triethylamine (TEA) (0.2% v/v aqueous) adjusted to pH 2.84 
with phosphoric acid. The flow rate was 1.1 mL/min and the retention time for the drug was 
~6 minutes.  A calibration curve over an ibuprofen concentration range of 0.05 (the limit of 
quantification) to 100 µg/mL was established. 
In vitro ibuprofen release testing using silicone membranes: The experiments (n = 5 replicates) 
were conducted at 37°C in vertical Franz diffusion cells (PermeGear Inc., Bethlehem, PA) with 
a receptor volume of 9 - 9.5 mL (accurately measured for each case). The receptor solution 
was phosphate-buffered saline (0.1 M, pH 7.4). The area of exposed silicone membrane 
surface was ~3 cm2 and the amount of gel deposited in the donor compartment of the diffusion 
cell was approximately 1 g. The cells were occluded with Parafilm (Bemis, Oshkosh, WI) 
immediately after the gel was dosed onto the membrane.  At various times up to 8 hours post-
initiation of the experiment, 1 mL of receptor medium was removed for drug analysis by HPLC 
and replaced with 1 mL of fresh receptor solution. The cumulative amount of drug that had 
penetrated the membrane from each formulation as a function of time was calculated. 
In vitro skin uptake and penetration of ibuprofen: Porcine skin used in these experiments was 
thawed and any excess hair was carefully trimmed away using scissors.  As above, 
experiments (n = 4-6 replicates) were conducted at 37°C in vertical Franz diffusion cells with 
phosphate-buffered saline in the receptor phase (7 – 7.5 mL, accurately measured). 
Approximately 0.64 g of gel was deposited on the skin surface facing the donor compartment 
of the diffusion cell, which was then occluded with Parafilm™. The exposed skin surface area 
was ~ 2 cm2.  At various times up to 8 hours post-initiation of the experiment, 1 mL of receptor 
medium was removed for drug analysis by HPLC and replaced with 1 mL of fresh receptor 
solution. The cumulative amount of drug that had penetrated the membrane from each 
formulation as a function of time was calculated. 
The pig skin was removed from the diffusion cell and pinned to a sheet of foam.  Any remaining 
formulation on the skin surface was immediately cleaned away using tissue (Kimberly Clark, 
Fisher, UK) and the stratum corneum (SC) was then removed by sequential tape-stripping 
(Scotch Book Tape, 3M, St Paul, MN).  To ensure reproducible SC removal from the skin, a 
circular template, from which a central hole (diameter 2 cm) had been cut out was centred 
over the skin to be tape-stripped.  As reported previously (Herkenne et al., 2007a; Kalia et al., 
2000; Russell et al., 2008), repeated tape-stripping was then undertaken with concomitant 
measurements of transepidermal water water loss (TEWL) (Aquaflux, Biox Systems Ltd, 
London, UK) to determine when most (>80%) if not all the SC had been removed and to 
estimate the total thickness of the SC as well.  This approach requires the amount of SC 
removed by each tape strip to be deduced from the weight difference (SE2-F, Sartorius AG 
Microbalance, Gottingen, Germany) in the tapes before and after SC stripping.  Each tape 
was then rolled inside a 1.5 mL HPLC vial and ibuprofen in the SC removed was quantitatively 
extracted by immersing the tape in 1 mL of a 90:10 mixture of acetonitrile and 1 M hydrochloric 
acid, and shaking overnight. The extracted solution was filtered (0.45μm nylon filter, SMI-
LabHut Ltd, Gloucestershire, UK) to prior to HPLC analysis.  Finally, the total SC uptake of 
drug, following an 8-hour treatment period, from the gel formulations tested was calculated.    
In vivo skin uptake of ibuprofen: Four healthy volunteers (aged 22-30 years, two male and two 
female), with no history of dermatological disease, participated in this study which was 
approved by the Research Ethics Approval Committee for Health (REACH; EP 14/15 2) of the 
University of Bath. Informed consent was obtained from all subjects. The ibuprofen 
formulations were applied to sites on the ventral forearm inside a foam ring and were occluded 
with plastic Hill Top chamber (16 mm, Sarasota, FL). Self-adhesive tapes (Mefix, Mölnlycke 
Health Care, Sweden) were used to cover the each of the treated sites to secure the chambers 
in place. An additional site on the forearm provided an untreated control at which no drug was 
applied. SC weights and TEWL measurements obtained at this site were used to determine 
the SC thickness of the subject (Kalia et al., 2000; Russell et al., 2008). 
In this case, the treatment time was 1 hour, at the end of which, the formulations were 
removed, the skin surface cleaned and the SC tape-stripped (with concomitant TEWL 
measurements) as described above.  The control, no-treatment site was tape-stripped to 
determine SC thickness on the forearm and to ensure that complete or nearly complete 
removal of the SC had been achieved where the formulations had been applied (N’Dri-
Stempfer et al., 2009, 2008). Ibuprofen extraction from the tapes and its subsequent analysis 
were as before.  The results provided profiles of drug concentration across the SC after a 1-
hour treatment as well as total drug uptake into the barrier within this time period. 
 
  
RESULTS & DISCUSSION 
Viscosity and pH of the gel formulations:  The pH values of the TOCN gels were between 4.8 
and 5.3; those of IbuleveTM and Sainsbury’s Gel were 7.0 and 8.2, respectively.  The 
viscosities of Sainsbury’s Gel, IbuleveTM and four of the TOCN formulations as a function of 
shear rate are shown in Figure 1.  The commercial products were the most viscous, by nearly 
an order of magnitude.  No significant difference in the viscosity of TOCN gels B, C and E was 
observed, even though formulation C contained only 1.2% w/w TOCN (compared to 1.8% w/w 
in B and E).  Gel D, comprising only 0.6% w/w TOCN, was the least viscous, about 1/10th of 
that of B, C and E.  Gel A, which contained 2% w/w propylene glycol was insufficiently semi-
solid to provide useful data.  
Figure 1: Viscosities of marketed and selected TOCN gels (mean ± SD; n = 3). 
 
In vitro ibuprofen release across silicone membranes:  The release profiles of ibuprofen from 
the two commercial products, and from TOCN formulations A and B, across a silicone 
membrane as a function of time are shown in Figure 2. Formulations A and B differ in that the 
former contains 2% w/w propylene glycol (and 2% less ethanol) and is significantly less 
viscous than the latter. 
It is clear from a one-way analysis of variance, followed by Tukey’s post-hoc test, that drug 
release from 4 hours onwards is significantly slower (p < 0.05) from Sainsbury’s Gel than from 
the other three formulations.  Interestingly, despite the very large differences in the viscosities 
of IbuleveTM, TOCN formulation A and TOCN formulation B (IbuleveTM is about 10-fold more 
viscous than formulation B, while formulation A is essentially a liquid), the release profiles of 
ibuprofen from these three vehicles are indistinguishable over the same 4 – 8 hour period of 
time.  It seems likely, therefore, that it is the relative affinity of the drug for the formulation 
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which controls its release kinetics rather than the rheological properties of the gel.  
Furthermore, it is worth noting that the predictive value of this experiment, in terms of drug 
delivery across the skin, is limited because a simple artificial membrane cannot simulate the 
complex manner in which a formulation’s excipients interact with the biological matrix of the 
stratum corneum. 
Figure 2: Ibuprofen release profiles across a silicone membrane from four formulations (mean 
± SD; n = 3). 
 
In vitro skin uptake and penetration of ibuprofen: The in vitro performance of the TOCN and 
commercial gels, in terms of their ability to facilitate drug uptake into, and permeation through 
porcine skin, was evaluated and the results are summarised in Figure 3 and Table 2.  In this 
case, formulation A was not studied because the presence of propylene glycol prevented gel 
formation. 
Figure 3: Ibuprofen permeation across porcine skin as a function of time from six gel 
formulations (mean ± SD; n = 4-6).  For the purposes of clarity, individual data points have 
been displaced slightly on the time axis.  
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 Table 2: Ibuprofen uptake into, and cumulative permeation through, porcine stratum corneum 
(SC) in vitro after application of six gels for a period of 8 hours (mean ± SD; n = 4-6). 
Formulation Ibuprofen uptake 
into SC (µg/cm2) 
Ibuprofen permeation 
through SC (µg/cm2) 
Sainsbury’s Gel 163 ± 40 270 ± 67 
IbuleveTM 202 ± 32 184 ± 43 
Formulation B   94 ± 23 238 ± 52 
Formulation C 265 ± 59 551 ± 176 
Formulation D 233 ± 44 402 ± 96 
Formulation E 179 ± 26 294 ± 106 
The penetration profiles of ibuprofen from all the gels was quite consistent, and the cumulative 
amount absorbed in 8 hours was statistically indistinguishable for Sainsbury’s Gel, IbuleveTM, 
and formulations B, D and E (1-way ANOVA followed by Tukey’s post-hoc test).  Total drug 
penetration from formulation C was significantly higher (p < 0.05) than that from all other gels 
except formulation D.  In terms of drug recovery from the SC at the end of the 8-hour 
experiment, there was a less than 3-fold variation across the six gels tested.  Nonetheless, 
the same statistical analysis revealed that ibuprofen uptake from formulation B was 
significantly less (p < 0.05) than that from IbuleveTM and formulations C, D and E, while drug 
recovery from formulation C was significantly higher than that from Sainsbury’s Gel and 
formulations B and E. 
Given the variability observed, and the relatively modest number of replicate experiments 
performed (n = 4-6), it seems unlikely that even the statistically different results obtained would 
translate into a noticeable discrimination in the eventual bioavailability of the drug at its site of 
action after topical application to the skin.  More important, however, is to draw attention to 
the fact that the TOCN gels investigated here performed at least as well (in terms of SC uptake 
and skin penetration) as the two commercial products even though the ibuprofen 
concentration in the new formulations was only 1% w/w, compared to 5% w/w in Sainsbury’s 
Gel and IbuleveTM.  
In previous work, diffusion profiles like those shown in Figure 3 have been fitted to the 
appropriate solution to Fick’s 2nd law of diffusion to extract so-called partitioning and diffusivity 
parameters (Herkenne et al., 2007a); the former is the product of the drug’s SC-formulation 
partition coefficient (K) and the diffusion path-length (h), while the latter is the ratio of the drug’s 
diffusivity (D) through the SC to the diffusion path-length squared (h2).  When this approach is 
applied to the data in Figure 3, the deduced values of D/h2 for ibuprofen delivered from all six 
tested gels fall in the range of 0.21 to 0.28 hr-1.  In contrast, while the best-fit values of K.h for 
ibuprofen are 6.9 cm for Sainsbury’s Gel and 4.7 cm for IbuleveTM (coefficients of variation are 
24% and 9% of the mean values, respectively), those for the four TOCN gels range from 28 
cm to 65 cm (%CVs being between 37% and 46%).  The more efficient delivery of the drug 
from the TOCN gels appears, therefore, to be the result of enhanced partitioning into the SC 
rather than alteration of the diffusion barrier per se.   
In vivo skin uptake of ibuprofen:  Given the relatively consistent performance of the TOCN 
gels in vitro, only one of these formulations (B) was compared to the two commercial products 
in the in vivo experiments.  Following a 1-hour application, the ibuprofen concentration profiles 
across the SC were deduced and the results in four subjects are shown in Figure 4.  No visible 
evidence of any skin irritation was apparent post-treatment with any of the gels used. 
Figure 4: Concentration profiles of ibuprofen across human SC in vivo (n = 4) following topical 
application of Sainsbury’s Gel, IbuleveTM and TOCN gel formulation B.  The data are presented 
as a function of relative depth into the SC (where 0 represents the SC surface, and 1 indicates 
the interface between the SC and the underlying, viable skin layers). 
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While the profiles for the marketed products were quite similar, as was the total recovery of 
ibuprofen from the SC (Table 3), the results from Formulation B were noticeably different: in 
this case, the concentration profile was almost linear (suggesting that steady-state had been 
reached, or nearly so) and the apparent partitioning of drug into the SC was significantly less 
than that from the commercial gels (as reflected in the y-axis intercepts of the concentration 
profiles) (Herkenne et al., 2008, 2007a, 2007b). 
Table 3: Ibuprofen uptake into human stratum corneum (SC) in vivo after application of three 
gels for a period of 1 hour (mean ± SD; n = 4). 
Formulation Ibuprofen uptake 
into SC (µg/cm2) 
Sainsbury’s Gel 83 ± 16 
IbuleveTM        115 ± 19 
Formulation B 53 ± 7 
The more rapid diffusion of the drug from Formulation B in the first hour of application may be 
the result of the relatively high level of ethanol in this vehicle that facilitated the establishment 
of a quite linear concentration profile in a rather short period of time.  That such an effect in 
the in vitro experiments was not observed, when the penetration profiles were analysed after 
an 8-hour exposure, might simply be due to the different time scale involved which resulted in 
the initial impact of the volatile solvent being missed. 
While total drug uptake in to the SC in 1 hour in vivo from the different formulations paralleled 
that seen in vitro after 8 hours, extrapolation of the concentration profiles in Figure 4 to the SC 
surface suggests that the apparent partitioning of ibuprofen from Sainsbury’s Gel and 
IbuleveTM is much greater than that from Formulation B.  While this finding is at odds with the 
in vitro data, the discrepancy may be due to technical reasons associated with the surface 
cleaning of the formulations at the end of the experiments.  It has been previously reported 
that the ‘dry-wipe’ method used here may sometimes prove somewhat less than efficient for 
the removal of residual formulation from the SC surface, especially for more viscous 
formulations, such as the two commercial products studied here (see Figure 1) (Wiedersberg 
et al., 2009).  The result of incomplete surface cleaning, of course, is that residual formulation 
is also removed with the initial SC tape-strips, artificially inflating the apparent levels of drug 
in the outer SC, and suggesting a higher SC-vehicle partition coefficient than is actually the 
case.  The impact of this shortcoming is less important in in vitro experiments of longer 
duration, especially when the donor compartment has been fully occluded for several hours.  
During this time, water moves from the receptor across the skin and into the formulation on 
the SC surface, reducing the viscosity of more ‘sticky’ vehicles, which then become easier to 
efficiently clean off when the experiment terminates. 
CONCLUSIONS 
The potential of TOCN-based gel formulations to deliver drugs topically into and through the 
skin has been clearly demonstrated.  When compared with two marketed products, which are 
available over-the-counter, the performance of the TOCN formulations, in terms of facilitating 
drug uptake into the SC (both in vitro and in vivo) and penetration through the skin (in vitro), 
was entirely respectable.  Of particular note is the fact that the novel formulations were, in 
large part, as efficient as the commercially available gels despite a drug loading that was only 
20% of the reference products.  This would be a considerable benefit, of course, for expensive 
drugs, as well as reducing potential, long-term adverse effects when such formulations are 
used chronically over large areas of skin. The work presented here serves as an initial proof-
of-concept for the idea of sustainable formulation development; however, further research 
would be required to optimise the gels and their development. 
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FIGURES & FIGURE LEGENDS 
Figure 1: Viscosities of marketed and selected TOCN gels (mean ± SD; n = 3). 
 
 
 
 
Figure 2: Ibuprofen release profiles across a silicone membrane from four formulations (mean 
± SD; n = 3). 
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Figure 3: Ibuprofen permeation across porcine skin as a function of time from six gel 
formulations (mean ± SD; n = 4-6).  For the purposes of clarity, individual data points have 
been displaced slightly on the time axis.  
 
 
Figure 4: Concentration profiles of ibuprofen across human SC in vivo (n = 4) following topical 
application of Sainsbury’s Gel, IbuleveTM and TOCN gel formulation B.  The data are presented 
as a function of relative depth into the SC (where 0 represents the SC surface, and 1 indicates 
the interface between the SC and the underlying, viable skin layers). 
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TABLES 
Table 1: Components (in %w/w) of the ibuprofen gel formulations studied. 
Formulation Ibuprofen 
Aqueous TOCN 
dispersiona 
Ethanol SDS 
Propylene 
glycol 
A 1.0 60 37 - 2.0 
B 1.0 60 39 - - 
C 1.0 60 39 - - 
D 1.0 60 39 - - 
E 1.0 60 39 0.07 - 
Sainsbury’s Gel 5.0 
hydroxyethylcellulose, sodium hydroxide, benzyl 
alcohol, isopropyl alcohol, purified water 
IbuleveTM 5.0 
industrial methylated spirit, carbomer, propylene 
glycol, diethylamine, purified water 
a For formulations A, B and E, the aqueous dispersion was prepared at a concentration of 1.8% w/w 
TOCN; for formulations C and D, 1.2% w/w and 0.6% w/w TOCN were used, respectively. 
 
Table 2: Ibuprofen uptake into, and cumulative permeation through, porcine stratum corneum 
(SC) in vitro after application of six gels for a period of 8 hours (mean ± SD; n = 4-6). 
Formulation Ibuprofen uptake 
into SC (µg/cm2) 
Ibuprofen permeation 
through SC (µg/cm2) 
Sainsbury’s Gel 163 ± 40 270 ± 67 
IbuleveTM 202 ± 32 184 ± 43 
Formulation B   94 ± 23 238 ± 52 
Formulation C 265 ± 59 551 ± 176 
Formulation D 233 ± 44 402 ± 96 
Formulation E 179 ± 26 294 ± 106 
 
Table 3: Ibuprofen uptake into human stratum corneum (SC) in vivo after application of three 
gels for a period of 1 hour (mean ± SD; n = 4). 
Formulation Ibuprofen uptake 
into SC (µg/cm2) 
Sainsbury’s Gel 83 ± 16 
IbuleveTM        115 ± 19 
Formulation B 53 ± 7 
 
